S100A8 and autoimmune disease: S100A8 and S100A9 levels are markedly increased in a wide range of inflammatory conditions, including autoimmune diseases, cancers, and neurodegenerative disorders, and they may serve as effective biomarkers for disease detection and prognosis (116).